Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Head and neck cancer+7

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

Registered drugNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Head and neck cancer+4

Not recruiting

InvestigationalNo placebo

Study of IPN01194 for Adults with Advanced Solid Tumors, Including Melanoma, Head and Neck Cancer, Pancreatic Cancer, and Colorectal Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ipn01194

Contact Research Centre

Head and neck cancer+3

Not recruiting

Registered drugNo placebo

Study of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Head and neck cancer+18

Not recruiting

Registered drugNo placebo

Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Head and neck cancer+3

Not recruiting

Registered drugNo placebo

Study of ALX148, Pembrolizumab, and Chemotherapy for Patients with Advanced Head and Neck Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Head and neck cancer

Not recruiting

Registered drug

Study of Monalizumab and Cetuximab for Patients with Recurrent or Metastatic Head and Neck Cancer Previously Treated with an Immune Checkpoint Inhibitor

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Head and neck cancer+5

Not recruiting

Registered drugNo placebo

Study of TG4001 and Avelumab for Patients with Advanced HPV-16 Positive Cancers

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Avelumab

Contact Research Centre

Head and neck cancer

Not recruiting

Registered drug

Study of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Head and neck cancer+1

Not recruiting

Registered drug

Study on the Safety of LSTA1 with Standard Care for Patients with Advanced Head and Neck Cancer or Cholangiocarcinoma

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Find therapies in clinical trials near you – page 3

33 trials match your criteria

Head and neck cancer+7

Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

Head and neck cancer+4

Study of IPN01194 for Adults with Advanced Solid Tumors, Including Melanoma, Head and Neck Cancer, Pancreatic Cancer, and Colorectal Cancer

Head and neck cancer+3

Study of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer

Head and neck cancer+18

Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

Head and neck cancer+3

Study of ALX148, Pembrolizumab, and Chemotherapy for Patients with Advanced Head and Neck Cancer

Head and neck cancer

Study of Monalizumab and Cetuximab for Patients with Recurrent or Metastatic Head and Neck Cancer Previously Treated with an Immune Checkpoint Inhibitor

Head and neck cancer+5

Study of TG4001 and Avelumab for Patients with Advanced HPV-16 Positive Cancers

Head and neck cancer

Study of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin

Head and neck cancer+1

Study on the Safety of LSTA1 with Standard Care for Patients with Advanced Head and Neck Cancer or Cholangiocarcinoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.